Detail Data
Volume (24h): 18,645 shares
P/E Ratio: /
Forward P/E: -3.07
EPS: -2.64 USD
Forward EPS: -0.57 USD
Number of Shares: 23,949,200 shares
Market Capitalization: 41,911,100.00 USD

Dividend

Dividend Value
Dividend Amount According to our data, the company Celularity does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a none recommendation for Celularity stock. The current number of analysts covering this company is No analyst coverage. The highest target price is / while the lowest target price is / The median target valuation set by analysts is / These forecasts and recommendations provide insight into how analysts view the future stock performance of Celularity.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Celularity stock is: none
Number of Analysts: Celularity is not covered by analysts.
Highest Target Price: /
Lowest Target Price: /
Median Target Price: /

Fundamental Indicators

Indicator Data
Total Revenue: 54,220,000.00 USD
Net Income: -57,892,000.00 USD
Price-to-Book (P/B): 4.46
PEG Ratio: /
Exchange: NasdaqCM
Industry: Biotechnology
Sector: Healthcare
Number of Employees: 120
Country: United States

Where to Buy Celularity Stock?

You can purchase Celularity stock on the NasdaqCM under the ticker symbol: CELU. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Celularity Stock

Indicator Value
Company Revenue: 54,220,000.00 USD
EBITDA: -30,629,000.00 USD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -2.64 USD
Book Value Per Share: 0.39 USD
Total Cash: 738,000.00 USD
Total Cash per Share: 0.03 USD
Total Debt: 68,836,000.00 USD
Debt to Equity Ratio: 7.79
Quick Ratio 0.27
Current Ratio 0.38
Free Cash Flow 10,324,625.00 USD
Operating Cash Flow -6,401,000.00 USD
Gross Margins 72.36 %
EBITDA Margins -56.49 %
Operating Margins -52.25 %
Profit Margins -106.77 %
Return on Assets -17.4 %
Return on Equity -232.5 %
Earnings Growth (1 year) -
Revenue Growth (1 year) 49.7 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 41,911,100.00 USD
Enterprise Value 110,009,152.00 USD
EV/Revenue 2.029
EV/EBITDA -3.592
Float Shares 11,684,589 shares
Shares Outstanding 23,949,200 shares
Held Percent Insiders 0.51 %
Held Percent Institutions 14.66 %
Shares Short 1,476,624
Shares Short Prior Month 1,676,219
Date Short Interest 2025-05-30
Short Percentage of Total Shares 6.17 %
Short Ratio 17.44
Beta 0.76
Short Percentage of Float 32.57 %
Implied Shares Outstanding 23,949,200

Frequently Asked Questions (FAQ)

According to our data, the company Celularity does not pay dividends yet, even in 2025.

Celularity shares are traded on the NasdaqCM stock exchange under the ticker: CELU. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

No prediction or recommendation from analysts has been issued for Celularity shares yet.

The total number of Celularity shares on the exchange is 23,949,200.00 shares, which at the current market capitalization gives the company a total valuation of 41,911,100.00 USD.